Week In Review: AIM Vaccine Stages $20 Million IPO On Hong Kong Exchange
AIM Vaccine conducted a very small IPO on the Hong Kong exchange, raising US$20 million, which netted the company only US$10 million. The IPO saw less than 1% of the company's shares sold.
Source: seekingalpha.com